| Anne B Deatkine, MD | |
|
1000 1st St N, Alabaster, AL 35007-8703 | |
| (205) 620-8100 | |
| Not Available |
| Full Name | Anne B Deatkine |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 37 Years |
| Location | 1000 1st St N, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154326353 | NPI | - | NPPES |
| 009912243 | Medicaid | AL | |
| 051535034 | Other | AL | BLUE CROSS |
| 051553914 | Medicaid | AL | |
| 1611283 | Other | AL | UHC |
| 4323624 | Other | AL | AETNA |
| 051524498 | Other | AL | BLUE CROSS |
| 051516732 | Other | AL | BLUE CROSS |
| 051516731 | Other | AL | BLUE CROSS |
| 009995645 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 17072 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coosa Valley Medical Center | Sylacauga, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Horizon Imaging, P.c. | 4385742675 | 3 |
News Archive
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets.
Scientists in Britain have identified a gene they say increases the risk of bowel cancer by 20%.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
› Verified 1 days ago
| Entity Name | Birmingham Radiological Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376594192 PECOS PAC ID: 8022922756 Enrollment ID: O20031118000002 |
News Archive
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets.
Scientists in Britain have identified a gene they say increases the risk of bowel cancer by 20%.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
› Verified 1 days ago
| Entity Name | Horizon Imaging, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437373628 PECOS PAC ID: 4385742675 Enrollment ID: O20070611000317 |
News Archive
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets.
Scientists in Britain have identified a gene they say increases the risk of bowel cancer by 20%.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anne B Deatkine, MD 2000a Southbridge Pkwy, Ste 300, Birmingham, AL 35209-7718 Ph: (205) 871-4274 | Anne B Deatkine, MD 1000 1st St N, Alabaster, AL 35007-8703 Ph: (205) 620-8100 |
News Archive
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets.
Scientists in Britain have identified a gene they say increases the risk of bowel cancer by 20%.
University of Oregon scientists have identified brain cells vital to how zebrafish socialize. When the neurons are disabled, their orientation to one another breaks down in ways similar to socialization problems seen in humans with autism spectrum disorders and schizophrenia.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
› Verified 1 days ago
Benjamin Glasgow Mcdaniel Jr., MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1022 1st St N, Ste103, Alabaster, AL 35007 Phone: 205-621-3930 Fax: 205-621-0998 | |
Stephen Dale Brawner, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1022 1st St N, Ste103, Alabaster, AL 35007 Phone: 205-621-3930 Fax: 205-621-0998 | |
Dr. Christopher Dean Jahraus, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1024 1st St N, Alabaster, AL 35007 Phone: 205-664-4051 Fax: 205-664-5538 | |
Patrick Grant, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 205-871-4274 | |
Daniel W Thompson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 205-620-8100 |